Information about De Scheerder Pharmaceuticals
My details
*
*
*
No warnings for this company
{{translate('company_activity_bron_' + bron)}}
NACE Description
{{activiteit.code}} {{activiteit.description}}

De Scheerder Pharmaceuticals (SRL)

BE 0752.564.602

Mariakerkegeest 12, 9030 Gent
Company information
Status
Active
Enterprise number
BE0752.564.602
VAT liability
Yes
Established
13-08-2020
Last balance sheet year
2024
Company size
Micro 0 FTE
Principal activity
Other business support service activities n.e.c.
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from De Scheerder Pharmaceuticals
{{translate("download")}}

Publications in the Belgian Official Journal from De Scheerder Pharmaceuticals

Date Publication
17-08-2020 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of De Scheerder Pharmaceuticals?
The VAT number of De Scheerder Pharmaceuticals is BE0752564602.
When was De Scheerder Pharmaceuticals founded?
De Scheerder Pharmaceuticals was founded on 13-08-2020.
What is the address of De Scheerder Pharmaceuticals?
The current registered office of De Scheerder Pharmaceuticals is located at Mariakerkegeest 12, 9030 Gent.
When was the last time De Scheerder Pharmaceuticals filed their annual financial statements?
The most recent financial statements of De Scheerder Pharmaceuticals were filed on 17-01-2025. You can view them here.
How many employees does De Scheerder Pharmaceuticals have?
There are currently no employees working at De Scheerder Pharmaceuticals or no workforce information is available.
What is the annual turnover of De Scheerder Pharmaceuticals?
At the time of its most recent financial statements, De Scheerder Pharmaceuticals did not publish any turnover figures. De Scheerder Pharmaceuticals reported a gross margin of €18,415.91.

Sources